**Second Edition – Biennale 2025**
_Theme: Cycle of Health and Cancer_

Biennale 2025 builds on the success of its [2023 inauguration](https://translacore.eu/page/biennale-2023), continuing the fusion of science and art to foster public understanding of health and disease. This year’s theme, Cycle of Health and Cancer, explores the delicate biological balance that sustains life, and how its disruption can lead to cancer.

Cancer arises from molecular errors, particularly in DNA, that disturb the cellular translation process, the conversion of genetic information into proteins. When this process is impaired by mutations, environmental stress, or epigenetic changes, it can lead to disease. Understanding and restoring this balance is crucial for health and recovery. 

The European initiative TRANSLACORE leads in this field, uniting researchers across disciplines to target translation control as a novel approach to cancer therapy. By investigating how cells regulate protein production under stress, TRANSLACORE is identifying new molecular targets and developing innovative treatments, including RNA-based therapies and translation-specific inhibitors. 

Each piece in the gallery reflects TRANSLACORE’s pioneering research, turning molecular data into meaningful design. This collaborative space engages the public, sparks dialogue, and celebrates the intersection of scientific discovery and artistic creativity.

[To find out more and view the poster, please visit the BIENNALE 2025 page. ](https://translacore.eu/page/biennale-2025)


Second edition - Biennale 2025

The Biennale 2025 marks the successful continuation and expansion of the groundbreaking 2023 edition, where science and art first joined to form a powerful platform for interdisciplinary dialogue. This year’s theme, Cycle of Health and Cancer, builds on past achievements by deepening public understanding and scientific exploration of the biological processes that govern health, disease, and recovery.

translacore-biennale-plakatuIPBL-2025-translacore-9.jpg

 COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. (www.cost.eu) | The TRANSLACORE Cost Action is bridging disciplines and expertise across Europe in order to advance an emerging field in cancer biology: translational control in cancer. It is providing a unique opportunity to understand this biological process leading to reconsider our view of gene expression control in this disease and deliver novel therapeutic opportunities.

Search in the Translacore

Second edition - Biennale 2025